Delivery Order SPE2DB22D2006-SPE2DB25FW0TB

Award Date 5/8/25
Potential Completion Date 5/9/25
Potential Value $27K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,921.66 firm-fixed-price delivery order is for the supply of 4,566,199,132 units of the medication Entresto 24 mg-26 mg tablets. The contract has an ultimate completion date of October 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $2,102.21, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,568,204,764 units of the medication Entresto 24 mg-26 mg tablets, with an ultimate completion date of May 12, 2025. The contract is a delivery order with a firm fixed-price pricing type, and there is no set-aside designation indicated. AmerisourceBergen Drug...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,113.26, is a delivery order for 60 tablets of the medication Entresto (97 mg-103 mg). The contract is not set aside and is for a firm fixed price. The contract has an ultimate completion date of May 6, 2025. Additionally, AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $34,916.94, is for the delivery of the drug Entresto 24 mg-26 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of May 9, 2024 and is structured as a firm fixed-price delivery order. This award is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,377.82 firm fixed-price delivery order is for the supply of Entresto 24 mg-26 mg tablets. The contract has an ultimate completion date of June 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the delivery of Entresto 24 mg-26 mg tablets in 60-count packages, with a ceiling value of $9,053.94 and a period of performance through May 16, 2024. The contract is a Delivery Order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $12,714.97, is for the delivery of Entresto 24 mg-26 mg tablets. It is a firm fixed-price delivery order contract with an ultimate completion date of April 30, 2025. The contract is not set aside and was awarded on April 29, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,688.58, is for the delivery of 4,568,000 units of the medication Entresto (24 mg-26 mg tablets, 180 count). The contract has an ultimate completion date of April 23, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $6,076.43 firm fixed-price delivery order is for 180 tablets of the medication Entresto, with a period of performance through November 22, 2023. This award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,344.27, is a delivery order for the drug Entresto (49 mg-51 mg tablet, 180 count) with a period of performance through January 24, 2025. The contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FW0TB
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,378.96 firm fixed-price delivery order is for the supply of 4,568,189,238 units of the medication Entresto 24 mg-26 mg tablets. The contract has an ultimate completion date of May 9, 2025.

Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This IDC enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The contract award described is not designated as a set-aside.

Generated 8/10/25, 1:05 AM